Why the study?
Does Angiotensin II regulate NAD(P)H oxidase expression and superoxide formation in human endothelial cells, and does AT1 receptor blockade reduce this expression in patients with coronary artery disease?
Does Angiotensin II regulate NAD(P)H oxidase expression and superoxide formation in human endothelial cells, and does AT1 receptor blockade reduce this expression in patients with coronary artery disease?
Angiotensin II induces proatherosclerotic oxidative stress via NAD(P)H oxidase in human endothelial cells, which can be mitigated by AT1 receptor blockade.
Answers are grounded in this paper and cite their sources.
AT1 blockade may reduce vascular oxidative stress; hypothesis-generating and should not yet change practice in CAD.
OBJECTIVE: Angiotensin II (Ang II)-mediated induction of vascular superoxide anion formation could contribute to the development of endothelial dysfunction, hypertension, and atherosclerosis. An NAD(P)H oxidase has been identified as a major endothelial source of superoxide anions. However, the molecular mechanism underlying the regulation of NAD(P)H oxidase activity in response to Ang II is not well understood. METHODS AND RESULTS: We investigated the dose-dependent regulation of superoxide anion formation and of NAD(P)H oxidase subunit expression in response to Ang II in human endothelial cells. Ang II regulates superoxide anion formation and the limiting subunit of endothelial NAD(P)H oxidase, gp91-phox, in a dose-dependent manner via Ang II type 1 (AT1) receptor-mediated induction and Ang II type 2 receptor-mediated partial inhibition at higher Ang II concentrations. Furthermore, AT1 receptor blocker therapy before coronary bypass surgery downregulates the gp91-phox expression in internal mammary artery biopsies of patients with coronary artery disease. CONCLUSIONS: Our data support a dose-dependent induction of proatherosclerotic oxidative stress in human endothelial cells in response to Ang II. The expression of NAD(P)H oxidase subunit gp91-phox is critical for endothelial superoxide anion formation. AT1 receptor blockade has an antiatherosclerotic and antioxidative potential by the reduction of oxidative stress in the vessel wall.
No takes yet. Share an insight, caveat, or question.
Rueckschloss et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: